Product Program year 2025 Source: CMS Open Payments

uTASWako AFP-L3

Device Medical Device

PDI 04987481164390

Open in the dashboard

General payments

$142,446

603 payments

Research payments

$853,515

4 payments

Through program year 2025, $142,446 in general payments and $853,515 in research payments were reported against uTASWako AFP-L3 (Medical Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $51,690 173
2025 Research $548,515 2
2024 General $43,858 237
2024 Research $305,000 2
2023 General $9,995 88
2022 General $23,002 44
2021 General $13,901 61

Breakdown

Who paid General payments · program years 2021–2025
  1. FUJIFILM Medical Systems USA, Inc. $142,446 603 payments
Top recipients General payments · program year 2025
  1. Giorgio Roccaro Transplant Hepatology · Atlanta, GA $5,297 10% · 4 payments
  2. Langley Porter Psychiatric Hospital Teaching hospital · CA $5,000 10% · 1 payment
  3. Mitchell Shiffman Gastroenterology · Newport News, VA $4,983 10% · 6 payments
  4. Neil Mehta Hepatology · San Francisco, CA $4,955 10% · 7 payments
  5. Piedmont Hospital Inc. Teaching hospital · GA $4,000 8% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $8,960 36% · 50 practitioners
  2. Transplant Hepatology Internal Medicine $5,997 24% · 11 practitioners
  3. Hepatology Internal Medicine $5,918 24% · 8 practitioners
  4. Internal Medicine $1,281 5% · 7 practitioners
  5. Transplant Surgery $701 3% · 6 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $14,134 27% · 5 recipients
  2. Georgia $12,464 24% · 22 recipients
  3. Virginia $8,401 16% · 11 recipients
  4. North Carolina $3,829 7% · 3 recipients
  5. Michigan $3,817 7% · 3 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

603 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record